Acadian Asset Management
MACK

Acadian Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Acadian Asset Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,849
Closed -$174K – 2198
2019
Q1 		$174K Buy
31,849
+28,895
+978% +$158K ﹤0.01% 1390
2018
Q4 		$9K Buy
+2,954
New +$9K ﹤0.01% 1619